Fig. 3From: Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in miceCharacterization of the liposomal preparations. A Diameter, PDI and D Zeta potential of the preparations. B LR and E LC of the preparations. C BER and F CUR releases from DEAE-DEX@LSDBC in SFG (0–2 h) and SIF (2–24 h) in vitro. Each bar represents the mean  ±  SD (n  =  3)Back to article page